Loading
Trial sites are paid per patient recruited, so nobody is paid to finish the study or report the answer. Shift part of the payment to completion and publication within a year.
Sponsors and public funders restructure site and investigator payments so that a meaningful share (for example 25%) is held back and paid on completion of follow-up, database lock and public results posting within twelve months of the primary completion date, with a further bonus for peer-reviewed publication of negative results. Academic centres pass this through to investigator research accounts. Trial non-reporting remains common years after completion, and academic trials in particular stall in analysis and writing because the incentive ends with the last patient.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Trials enrol too few, too slowly.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Trials enrol too few, too slowly.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Trials enrol too few, too slowly.
Shares Funder bonuses for releasing results and data within six months, negatives included, Promote academics for trials completed, data shared and findings replicated.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Failures are hidden.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
Shares EU Clinical Trials Register / CTIS, Trials enrol too few, too slowly.
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.